High grade prostatic intraepithelial neoplasia (HGPIN) is widely regarded as the precancerous. The aim of this study was to determine PSA related parameters in patients with initial PSA values 2-10 ng/mL and diagnosis of HGPIN without finding carcinoma at the time of their first needle biopsy. Study groups consisted of 100 men who were diagnosed HGPIN, 84 with cancer and 183 with benign hyperplasia on first biopsy of prostate. Total PSA and free PSA were measured and ratio free/total PSA and PSA density calculated. Mean values of these parameters were compared, and receiver operating characteristic curves were used for comparison of PSA related parameters to discriminate groups of patients. Total PSA, free PSA level and PSA density in patients with HGPIN (6.388 ng/mL) did not differ significantly compared to prostate carcinoma (6.976 ng/mL) or benign prostatic hyperplasia (6.07 ng/mL) patients. Patients with HGPIN had significantly higher ratio free/total PSA than those with prostate carcinoma (0.168 vs 0.133), but significantly lower than patients with benign prostatic hyperplasia (0.168 vs 0.185). Ratio of free/total PSA significantly discriminate HGPIN from prostate carcinoma with sensitivity 84.52 and specify 45.00 at cut-off point of ≤ 0.18. Values of PSA, free PSA and ratio free/total PSA in cases of HGPIN appear to be intermediate between prostate cancer and normal levels. Ratio of free/total PSA may help in decision to repeat biopsies in the presence of HGPIN on biopsy, without concomitant prostate cancer, in patients suitable for curative treatment, with normal digito-rectal examination and trans-rectal sonography.
IntroductIon
High-grade prostatic intraepithelial neoplasia (HGPIN) is proliferation of highly atypical cells within the pre-existing prostatic acini and ducts [1] . HGPIN shows no specificity on digital rectal examination (dRe) and transrectal ultrasonography (TRUS) [2, 3] . The natural biological behavior of HGPIN is yet poorly understood, but it is considered as a precursor of prostate cancer and is frequently associated with it. HGPIN is found in 85% of radical prostatectomies performed for prostate carcinoma. HGPIN in prostate biopsy is a risk factor for detection of prostate carcinoma in subsequent biopsies with the incidence ranges from 21% to 73% [4, 5, 6, 7] . Atypical small acinar proliferation (ASAP) adjacent to HGPIN seems to confer an even higher risk for subsequent cancer detection of 53% [8, 9, 10] . HGPIN seems to be more often associated with the characteristics of the poor prognosis for relapse of prostate cancer [11] . HGPIN and prostate carcinoma share many similarities in epidemiology, genetics, morphology, as well as in location and clinical features [12] . HGPIN often shows moderately increased serum level of PSA. Levels of PSA in prostatic intraepithelial neoplasia have been correlated with its grades [4] . Coexistence of HGPIN with prostate carcinoma has been considered the most likely cause of PSA elevation. A low percentage of free PSA (fPSA) has also been observed in HG-PIN. The question is whether an elevation of serum PSA and decrease of fPSA in HGPIN can be explained by concomitant prostate cancer or by a premalignant lesion itself [13] . It is widely thought that simple HGPIN detected by extended needle biopsy has no therapeutic implications, but should be followed up at regular intervals [14] . HGPIN has a substantial risk for prostate cancer in subsequent biopsies and should necessitate further investigation in patients who are candidates for radical treatment of localized prostate cancer [2, 15, 16] . The aim of this study was to determine level of total prostate Table 2 , and Figure 1 . Receiver operating characteristic curves were used for comparison of PSA related parameters to discriminate patients with PCa, HGPIN and BPH. The greatest area under the curve was observed for R fPSA/PSA both between PCa and HGPIN and PCa and BPH (0.658 and 0.682 respectively). According this analysis PSA significantly discriminate PCa from BPH, fPSA PCa from HGPIN and PSAd PCa from BPH (Table 3) .
dIscussIon
HGPIN is considered to be a premalignant lesion, with a close association of prostate cancer in biopsy and prostatectomy specimens. A biopsy finding of HGPIN necessitates further investigation in patients who are candidates for radical treatment for localized prostate cancer. Serum PSA, dRe and TRUS are predictors of later cancer found on repeated biopsy [15, 16] . A palpable nodule or tumour-suspicious TRUS finding, in conjunction with a finding of HGPIN on prostate biopsy, should prompt repeated biopsy [5] . The incidence of later cancer is extremely high when PSA > 10 ng/ mL, and this is indication for repeated biopsies even in the absence of HGPIN [5] . A substantial overlap was found between patients with and without cancer in intermediate PSA level from 4 to 10 ng/mL [17] . There is no consensus on clinical management of patients with HGPIN, indeterminate dRe finding and PSA level between 4 and10 ng/mL. our study group consisted of 100 men who were diagnosed HGPIN without concomitant prostate cancer on first biopsy. These patients were age between 50 and 70 years, mean 65.1 years. They were without definitive signs of prostate carcinoma on dRe and TRUS. All had PSA level in grey zone. Such patients, if they had prostate carcinoma, would be candidates for radical treatment [18] . Serum free and total PSA levels were measured. Ratio of free and total PSA, and PSAd were calculated. These parameters were compared to that in 85 men with prostate cancer (mean age 65. The concentration of non-complexed (free) PSA contributes little disease specific information in comparison with total PSA. R fPSA/tPSA on the other hand significantly enhances the efficiency of test, in particular in the "diagnostic grey zone" of PSA.
For reasons yet poorly understood, higher ratio occurs in patients without carcinoma than in these with prostate cancer [16] . In our study, patients with HGPIN had significantly higher R fPSA/tPSA than these with PCa (0.168 vs 0.133), but significantly lower than patients with BPH (0.185). These parameters and results of comparisons have been numerically similar to the respective value in other studies [9, 10, 20, 21] . The volumes of prostate in patients with BPH and HG-PIN were similar (48.699 mL and 48.378 mL respectively).
Patients with PCa had mean value of prostate volume of 44.412 mL. The differences from previous groups were not statistically significant. PSAd were similar in patients with HGPIN, PCa and BPH (0.1564, 0.1616 and 0.1564 respectively). In other studies, PSAd also differed in none of the subgroups, and did not provide additional information [3] . According to our results, and results from other studies, HG-PIN has levels of PSA related parameters intermediate between PCa and BPH. More probably that may be explained by concomitant prostate cancer, as they are two closely related entities [15] . But intermediate level of PSA and R fPSA/tPSA might be result of higher production of PSA in HGPIN like carcinoma, as they share many similarities. HIPN occurs most frequently in the peripheral zone of the prostate and is usually located in close proximity to prostate cancer. deoxyribonucleic acid ploidy in HGPIN follows the [9, 20] . Ratio fPSA/tPSA of ≤ 0.18 differentiates malignant from benign prostate pathology or latent from manifest cancer with a specificity of 91% and selectivity of 69% [22] . 
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